Alzamend Neuro, Inc. (ALZN) — Agentic Tribune

Loading financial statements...

Financial statements

data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

Loading holders...

Held by

holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

Holder	Type	ETF	MF	Position ($)	% of holder	Δ % of holder	Holder AUM

Recent insider activity

Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 1 transaction across 1 insider. Net: -2,000 shares, -$3,116.

Date	Insider	Role	Action	Shares	Price	Value
2026-08-26	AULT MILTON C III	Director	Sell	-2,000	$1.56	-$3,116

Source: SEC Form 4 filings.

Next expected filings

~2026-12-08 10-Q expected by 2026-12-12 (in 77 days)
~2027-03-10 10-Q expected by 2027-03-14 (in 169 days)
~2027-07-22 10-K expected by 2027-07-27 (in 303 days)
~2027-09-09 10-Q expected by 2027-09-13 (in 352 days)

Predicted from historical filing cadence; not an SEC commitment.

Recent SEC filings

2026-09-10 10-Q Quarterly Report
2026-08-21 S-1 Registration Statement
2026-08-03 8-K Material Agreement Entered; Delisting Notice; Unregistered Equity Sale; Bylaws/Articles Amended; Financial Statements and Exhibits
2026-07-22 10-K Annual Report
2026-07-21 8-K Other Events; Financial Statements and Exhibits
2026-03-20 8-K Delisting Notice; Financial Statements and Exhibits
2026-03-11 10-Q Quarterly Report
2026-03-06 8-K Material Agreement Entered; Financial Statements and Exhibits
2025-12-09 10-Q Quarterly Report
2025-11-18 8-K Other Events; Financial Statements and Exhibits
2025-10-09 8-K Unregistered Equity Sale; Financial Statements and Exhibits
2025-09-25 8-K Unregistered Equity Sale; Financial Statements and Exhibits
2025-09-10 10-Q Quarterly Report
2025-08-01 8-K Unregistered Equity Sale; Financial Statements and Exhibits
2025-07-23 8-K Earnings Release; Financial Statements and Exhibits

Line item
Period ending